Access cutting-edge liver cancer treatment through this clinical trial at a research site in Oklahoma City. Study-provided care at no cost to qualified participants.
Access liver cancer specialists in Oklahoma City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related liver cancer treatment provided free
This is a multi-center, open-label phase IIA study that investigates the preliminary efficacy of Trans-arterial Tirapazamine Embolization (TATE) treatment of liver cancer followed by a PD-1 checkpoint inhibitor (nivolumab). Patients with two types of cancers will be enrolled, advanced hepatocellular carcinoma (HCC),and metastatic gastric cancer. All enrolled patients need to have liver lesions and have progressed on a prior immune checkpoint inhibitor.
Sponsor: Teclison Ltd.
Check if you qualify for this liver cancer clinical trial in Oklahoma City, OK
If you're searching for liver cancer treatment options in Oklahoma City, OK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oklahoma City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced liver cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.